Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02757898 · ClinicalTrials.gov registry record · Phase 1
Transfusion of Biotinylated Red Blood Cells
A Phase 1 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT02757898 is a Phase 1 study that has completed, run by Emory University. The registered enrollment target is 5 participants.
The verdict
NCT02757898, a Phase 1 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this research is to study how red blood cells (RBCs) survive in a person's circulation, and how that survival may be different in red blood cells that are donated and stored prior to being transfused. Investigators will study this by collecting blood samples from participants, "labeling" RBCs with a naturally occurring vitamin, biotin. The RBCs will then be re-infused back into the participant and blood samples will be taken weekly for 10 weeks to assess the number of labeled cells in the samples.
Interventions
- DRUG Biotin-Labeled Red Blood Cells (RBCs)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-01-11 |
| Est. Completion | 2018-11-13 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02757898
The ClinicalTrials.gov registry entry for NCT02757898 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biotin-Labeled Red Blood Cells (RBCs) is the first listed.
NCT02757898 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02757898 about?
NCT02757898 is a clinical study titled "Transfusion of Biotinylated Red Blood Cells". The purpose of this research is to study how red blood cells (RBCs) survive in a person's circulation, and how that survival may be different in red blood cells that are donated and stored prior to being transfused. Investigators will study this by collecting blood samples from participants, "labeli...
What is the current status of trial NCT02757898?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2017-01-11. Estimated completion is 2018-11-13.
What interventions are being tested in trial NCT02757898?
The interventions under investigation include: Biotin-Labeled Red Blood Cells (RBCs) (DRUG).
Who is sponsoring clinical trial NCT02757898?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.